oHSV expressing anti(α)-human CD47 IgG1 or IgG4 antibody were capable of blocking CD47, an immune checkpoint in glioblastoma cells, thereby decreasing local tumor size and improving survival in murine models of glioblastoma79. The gene discussed is CD47; the disease is neoplasm.